They were the ones that said Trump would go away for a little while and now they're saying Trump made a deal with the elites to stop their bullshit. Trump gathered up all their dirt through NSA and is holding it against them all. Pretty cool.
"Aytu BioScience Announces Positive Clinical Results from Healight(TM) Pilot Study in SARS-CoV-2 Patients
Mon, March 8, 2021, 2:01 PM
AYTU +5.05%
Data indicate endotracheal UVA light catheter therapy reduces SARS-CoV-2 viral load and improves clinical outcomes in mechanically ventilated SARS-CoV-2 patients
ENGLEWOOD, CO / ACCESSWIRE / March 8, 2021 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that data from a first in-human, open label, clinical trial in SARS-CoV-2 patients has been released.
The pre-print publication titled "Endotracheal application of ultraviolet A light in critically ill severe acute respiratory syndrome coronavirus-2 patients: A first-in-human study" concluded that endotracheal UVA light treatment was associated with a significant reduction of SARS-CoV-2 viral load and improvement in WHO clinical severity scores. Additionally, the endotracheal UVA light treatment did not result in any serious adverse device effects and was well tolerated.
A total of five critically ill, mechanically ventilated COVID-19 patients underwent UVA light therapy for five consecutive days. The UVA light catheter was inserted into an endotracheal tube (ETT) and illuminated for 20 minutes during each treatment. The endotracheal (ET) treatment resulted in significant logarithmic reduction of the SARS-CoV-2 viral load of the ET aspirate, which was the study's primary endpoint. Average log changes from baseline to day five and day six were -2.41 (>99%, p=0.0018) and -3.2 (>99.9%, p=0.0005), respectively. WHO clinical severity scores improved by an average of 1.6 and 3.6 points on day 15 and day 30, respectively. Excluding subject two, who had undetectable viral load, WHO clinical severity scores improved by 4.75 points on day 30. Importantly, no serious adverse device effects were observed, and no early treatment discontinuation occurred.
Josh Disbrow, Chief Executive Officer of Aytu BioScience, commented, "We believe the Healight technology can become an important tool for fighting the global COVID-19 pandemic, and we look forward to continuing discussions with the FDA on the advancement of this technology. There may be additional anti-infective applications for Healight beyond COVID-19, so having this initial proof of concept data gives us a great deal of enthusiasm for the potential of this investigational device. I would like to thank the team and our collaborators for the work that went into conducting this study and generating this data."
Aside from coronavirus, utilization of internal UVA light may have numerous other respiratory applications. Aytu BioScience will continue to engage with researchers in multiple therapeutic areas to continue to build on this technology platform.
The data have been published in MedRxiv, an online archive for health science pre-print manuscripts that are not yet peer reviewed. The manuscript has been submitted for peer review.
The complete study manuscript can be accessed at:
https://www.medrxiv.org/content/10.1101/2021.03.05.21252997v1.article-metrics
About Aytu BioScience, Inc.
Aytu BioScience is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. Aytu currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The portfolio includes Natesto®, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or "Low T"), ZolpiMist®, the only FDA-approved oral spray prescription sleep aid, Tuzistra® XR, the only FDA-approved 12-hour codeine-based antitussive syrup, Karbinal® ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor® and Tri-Vi-Flor®, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency. Aytu also distributes a COVID-19 IgG/IgM rapid antibody test and a rapid COVID-19 antigen test. These tests are used separately in the rapid, qualitative diagnostic assessment of the 2019 Novel Coronavirus. Additionally, Aytu has licensed worldwide rights to develop the Healight™ technology platform. Healight is an investigational medical device being studied as a prospective treatment for COVID-19 and other respiratory infections."
If Marjorie Taylor Greene was a good Representative she'd talk about how Dominion Voting systems should be outlawed across the land. That is what matters ... that is what needs to be changed. She's fluff ... talking about fluff.
They've increased the amount of dependents on many people's tax returns- this increases the amount of work pay but decreases the amount of tax return pay .... it causes an employee to pay more in taxes at the end of the year.
If a person files correctly ... meaning they file the amount they are supposed to pay and not what their company said ... it will cause a huge discrepancy in what is owed ... but they are supposed to pay what is owed because that is what was filed to IRS.
They increased the rate of pay to people to increase the amount it takes to come up with the money when it comes time for taxes that all of a sudden have to be paid instead of earned. When this all goes down - there won't be a surplus of funds ... there will be a shortage ... combined with the electric bills of the middle U.S. there will be a massive shortage of funds circulating to the positive in the U.S.
It will start a Venezuela effect.
It may be because of Trump's tax reduction which caused people to make more money but now they're claiming more money from people ... many Accountants are catching whatever the fuck it is ... they're saying it makes "no sense" unless corporations have changed claims. Of course, it will be confusing like ERCOT to confuse the masses.
It did pop ... watch til the end